Foot infections range from superficial skin infections (cellulitis) to deep soft tissue infections (abscess) and bone infections (osteomyelitis). Diabetic foot ulcers are open wounds on the foot that develop in patients with diabetes due to neuropathy, vascular insufficiency, and impaired immune function — and represent a major cause of foot infection, hospitalization, and lower extremity amputation. Early and accurate diagnosis is essential to limb preservation.
Foot infection and diabetic foot ulcers are closely linked to Charcot foot, which shares many clinical features in the acute phase — both present with a warm, red, swollen foot in a diabetic patient, and the two conditions can coexist. MRI is the most reliable way to distinguish infection and osteomyelitis from Charcot neuroarthropathy, as this distinction fundamentally changes management. Patients with longstanding diabetes and neuropathy are also at increased risk of Charcot neuroarthropathy developing following any foot wound or ulcer.
Causes
Diabetes-related risk factors
Diabetes is the leading risk factor for severe foot infections. Peripheral neuropathy eliminates protective sensation, allowing unnoticed wounds and repetitive trauma to progress undetected. Peripheral vascular disease impairs the blood flow necessary for wound healing and immune defense. Chronic hyperglycemia further compromises neutrophil function and tissue healing capacity, creating a hostile environment for wound resolution.
Direct bacterial entry
Most foot infections begin with a break in the skin — from an ulcer, puncture wound, blister, surgical incision, or fungal infection (tinea pedis) between the toes. Common pathogens include Staphylococcus aureus (including MRSA), Streptococcus species, and mixed aerobic-anaerobic flora in chronic, deep wounds. Infection tracks along fascial planes and tendon sheaths, rapidly spreading to deep compartments and bone if not treated promptly.
Other contributing conditions
Immunocompromised states (renal failure, immunosuppressive therapy, HIV), malnutrition, peripheral vascular disease unrelated to diabetes, and chronic skin conditions all substantially increase foot infection risk and impair treatment response.
Symptoms
Symptoms vary significantly by depth and severity. Superficial infections produce redness, warmth, swelling, and tenderness around a wound. Deeper infections may produce purulent drainage, foul odor, and visible proximal tracking of erythema. Critically, patients with diabetic neuropathy may have surprisingly mild or absent pain despite severe, limb-threatening infection — making clinical reliance on pain as a severity indicator dangerous in this population. Systemic signs including fever, chills, elevated heart rate, and worsening blood glucose control indicate spreading infection requiring urgent evaluation. Osteomyelitis classically produces a wound that probes to bone — a finding with high specificity for bone infection.
Diagnosis
Clinical assessment begins with thorough wound inspection, depth probing (the probe-to-bone test carries high specificity for osteomyelitis when positive), and evaluation for systemic signs of sepsis. Laboratory studies — white blood cell count, ESR, CRP, HbA1c, and blood cultures when indicated — help stratify severity and guide antibiotic selection. Wound cultures from deep tissue (not swabs) provide the most reliable microbiologic data.
MRI is the imaging study of choice for foot infections and is indispensable when osteomyelitis is suspected or when the clinical picture is complex. MRI identifies bone marrow signal changes diagnostic of osteomyelitis, soft tissue abscesses requiring surgical drainage, fascial plane involvement, and the extent of necrotic tissue guiding surgical debridement. Most importantly, MRI is the most reliable tool for distinguishing infection from Charcot neuroarthropathy — both show bone marrow edema, but osteomyelitis characteristically involves cortical destruction, overlying soft tissue ulceration, sinus tracts, and abscess formation, while Charcot shows a more diffuse, joint-centered pattern without cortical breakthrough or abscess. X-rays show late osteomyelitis changes (cortical erosion, periosteal reaction) but are insensitive for early bone infection.
Severity Classification
Diabetic foot infections are classified by severity using the IDSA/IWGDF system:
- Mild: Infection involving only skin and subcutaneous tissue, with less than 2 cm of surrounding erythema and no systemic signs. Oral antibiotics and outpatient management are typically appropriate.
- Moderate: Infection with greater than 2 cm of erythema, or involving deeper tissues — fascia, muscle, tendon, joint, or bone — without systemic signs. Often requires intravenous antibiotics and surgical consultation.
- Severe: Infection with systemic signs (fever, tachycardia, hypotension) or significant metabolic derangement. Requires urgent hospitalization, intravenous antibiotics, and emergent surgical evaluation.
The Wagner and University of Texas classifications further grade diabetic foot ulcers based on wound depth and the presence of infection or ischemia, providing a complementary framework for wound management planning.
Treatments
Treatment is multidisciplinary — involving infectious disease, vascular surgery, orthopedic or podiatric surgery, endocrinology, and wound care specialists — and is directed at controlling infection, healing the wound, and preventing recurrence and amputation.
Wound care and offloading:
Regular sharp debridement of necrotic and infected tissue, moist wound dressings appropriate to wound stage, and complete offloading of the wound are the cornerstones of ulcer management. Total contact casting is the gold standard for offloading plantar ulcers. Glucose optimization, nutritional support, and treatment of underlying peripheral vascular disease are prerequisites for wound healing — no wound will heal in an ischemic foot without revascularization.
Antibiotic therapy:
Antibiotic selection is guided by wound culture results and infection severity. Mild infections often respond to oral antibiotics targeting skin flora. Moderate to severe infections and osteomyelitis require intravenous antibiotics, frequently for 4–6 weeks in the case of bone infection. MRSA coverage must be considered in patients with prior healthcare exposure or chronic wounds.
Surgical treatment:
Surgical debridement of infected and necrotic tissue, drainage of abscesses, and resection of infected bone are frequently necessary. The goal is to achieve viable, clean wound margins that can support healing. Revascularization (bypass or endovascular procedures) is essential when significant peripheral arterial disease limits healing. In severe or uncontrolled cases, partial foot amputation (ray resection, transmetatarsal amputation) or more proximal amputation may be required to control infection and preserve the patient's life.
Prevention — the most important intervention:
For patients with diabetes, prevention is far more effective than treatment. Daily foot inspections in good light, protective footwear at all times (never barefoot), meticulous glycemic control, prompt attention to any skin break or wound, and regular professional foot examinations are the essential pillars of diabetic foot care. Early presentation at the first sign of infection dramatically improves outcomes and amputation-free survival.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Foot and Ankle MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.